MIRA INFORM REPORT

 

 

Report Date :

21.12.2013

 

IDENTIFICATION DETAILS

 

Name :

PFIZER S.R.L.

 

 

Registered Office :

Virrey Loreto No.2477, Buenos Aires City

 

 

Country :

Argentina

 

 

Financials (as on) :

30.11.2010

 

 

Date of Incorporation :

23.09.1998

 

 

Legal Form :

Liability Limited Company

 

 

Line of Business :

Engaged in production, processing, industrialization, import, export of drugs and chemical, biological and medicinal products.

 

 

No. of Employees :

650

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit : 

USD 30,00,000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Unknown 

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30th, 2013

 

Country Name

Previous Rating

(30.06.2013)

Current Rating

(30.09.2013)

Argentina

B1

B1

 

Risk Category

ECGC Classification

 

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

argentina ECONOMIC OVERVIEW

 

Argentina benefits from rich natural resources, a highly literate population, an export-oriented agricultural sector, and a diversified industrial base. Although one of the world's wealthiest countries 100 years ago, Argentina suffered during most of the 20th century from recurring economic crises, persistent fiscal and current account deficits, high inflation, mounting external debt, and capital flight. A severe depression, growing public and external indebtedness, and an unprecedented bank run culminated in 2001 in the most serious economic, social, and political crisis in the country's turbulent history. Interim President Adolfo RODRIGUEZ SAA declared a default - at the time the largest ever - on the government's foreign debt in December of that year, and abruptly resigned only a few days after taking office. His successor, Eduardo DUHALDE, announced an end to the peso's decade-long 1-to-1 peg to the US dollar in early 2002. The economy bottomed out that year, with real GDP 18% smaller than in 1998 and almost 60% of Argentines under the poverty line. Real GDP rebounded to grow by an average 8.5% annually over the subsequent six years, taking advantage of previously idled industrial capacity and labor, an audacious debt restructuring and reduced debt burden, excellent international financial conditions, and expansionary monetary and fiscal policies. Inflation also increased, however, during the administration of President Nestor KIRCHNER, which responded with price restraints on businesses, as well as export taxes and restraints, and beginning in 2007, with understating inflation data. Cristina FERNANDEZ DE KIRCHNER succeeded her husband as President in late 2007, and the rapid economic growth of previous years began to slow sharply the following year as government policies held back exports and the world economy fell into recession. The economy in 2010 rebounded strongly from the 2009 recession, but has slowed since late 2011 even as the government continued to rely on expansionary fiscal and monetary policies, which have kept inflation in the double digits. The government expanded state intervention in the economy throughout 2012. In May the Congress approved the nationalization of the oil company YPF from Spain's Repsol. The government expanded formal and informal measures to restrict imports during the year, including a requirement for pre-registration and pre-approval of all imports. In July the government also further tightened currency controls in an effort to bolster foreign reserves and stem capital flight.

 

Source : CIA

 

 


Registered Name 

 

PFIZER S.R.L.

CUIT.Nº.: 30-50351851-8

 

 

Summary 

 

FOLLOWER OF ACTIVITIES, INCORPORATED IN 1998. NO FINANCIAL DATA PROVIDED ONLY TO BANKS AND TAX COMPTROLLERS, BALANCE SHEET AS 30/11/2010 LAST KNOWN. NO NEGATIVE REGISTERED.  APT FOR CURRENT CREDITS AND ADDITIONAL GUARANTEES.
 

 

Operations 

 

> DRUGS FOR HUMAN USE
> PHARMACEUTICALS
> COMERCIALIZATION
> DISTRIBUTION

 

 

Legal Structure 

 

Legal form:                    Liability limited company
Created:                        23/09/1998
Registered R.P.C.:         09/10/1998
Duratiòn:                       99 years
Credit Limit                    USD 30,00,000

End of fiscal year:          30/11

Afip 20 de Defensa 135 de Subsuelo en la Ciudad de Buenos Aires.

 

 

 

Contact 

 

Accountant: Javier de Lerma

Legal, administratión and sales: Virrey Loreto No.2477, Buenos Aires City, Repúblic of Argentina.

Phone:              (54-11) 4788-7000
E.Mail:              urabaa@pfizer.com
Website:           www.pfizer.com.ar

 

 

Partners 

 

General manager:          ANNIE MARIE JOSE FRANCINE NIJS
Manager:                       MARIA COSTANZA LOSADA

The first of those is responsible for the management and administration of the company, in its capacity as manager, with the use of the firm name individually.

 

 

Corporate Stock 

 

SOCIAL CAPITAL $ 568.088.680.-

Is hereby given that by Reunion of members held on 20/09/2012, and under excision - fusion of Pfizer SRL and Alpharma of Argentina SRL, was resolved to reduce the share capital of the socuedad in the sum of $ 27,364,005. ie the sum of $ 595,452,680 to the sum of $ 568,088,680, and to amend Article 5 of the social contract. Maria Fernanda Molina, authorized by Reunion Pfizer SRL Partner 20/09/20125 date.

Official Gazette of the Republic Argentina - No. 32524 of 16/11/2012

 

 

History 

 

It is able to demonstrate that the activities outlined were initiated years ago by business name PFIZER ARGENTINA SACI, as a subsidiary of a foreign company, operating under the legal status until 1954.

At that time and in order to continue with the efforts that the company was developing, is organized as a continuation PFIZER SA, incorporated on 25/08/1954 and registered with the Public Registry of Commerce on 06/04/1956.

By then the company was established with central offices located in street Viceroy Loreto 2477, Capital Federal, and laboratories Avda John Mc Keen 3501, Moreno (BA), Avda Circunvalacion s / n º, City Bell (BA) and The Talas, Pdo. Berisso (BA).

For minutes of the Extraordinary General Assembly of 23/09/1998 deed No. 693 resolved to transform that company into Limited Liability going to operate under the current name of PFIZER SRL, aiming at the production, processing, industrialization, import, export of drugs and chemical, biological and medicinal products.

As of 21/11/2007 it was informed that membership meeting held on 28/09/2007, SEARLE ARGENTINA SRL, working its dissolution without liquidation adding that in that year the company had absorbed Pharmacia ARGENTINA SA

Was also related to PFIZER HEALTH AB SUCURSAL ARGENTINA, located in N. Avda.Leandro 928 7th of.721 Alem, Buenos Aires. This company by decision of the Board of the Parent Company of 22/11/2005, resolved to liquidate.

The company with over 15 years of experience is present in 180 countries and has more than 11,000 total empeados whose common feature is to accept the challenge of providing solutions to what the needs of those suffering from disease.

Every day, 40 million people worldwide are treated with medication Pfitzer.

 

 

Economic-Financial Position 

 

 Balance sheet as 30/11/2010 (last known) expressed in pesos argentinos:


ASSETS CURRENT              757.735.250

ASSETS NON-CURRENT          171.388.952

LIABILITIES CURRENT         514.506.418

LIABILITIES NON-CURRENT      27.697.210

NET WORTH                   386.919.574

NET SALES                   826.611.565

FINAL UTILITY                42.409.758

 

Balance Sheet   

 

Balance Sheet/s

30/11/2010

30/11/2009

30/11/2008

Total Assets

$ 929.123.202,00

$ 406.179.960,00

$ 341.750.093,00

Current Assets

$ 757.734.250,00

$ 335.201.179,00

$ 268.917.294,00

Banks

$ 459.017.040,00

$ 0,00

$ 0,00

Accounts Receivables

$ 0,00

$ 0,00

$ 0,00

Inventory

$ 298.717.210,00

$ 83.837.061,00

$ 89.470.612,00

Fixed Assets

$ 0,00

$ 0,00

$ 0,00

Non-Current Assets

$ 171.388.952,00

$ 70.978.781,00

$ 72.832.799,00

Investments

$ 0,00

$ 0,00

$ 0,00

Total Liabilities

$ 542.203.628,00

$ 80.388.585,00

$ 80.245.628,00

Current Liabilities

$ 514.506.418,00

$ 67.085.155,00

$ 68.887.521,00

Non-Current Liabilities

$ 27.697.210,00

$ 13.303.430,00

$ 11.358.107,00

StockHolders Equity

$ 386.919.574,00

$ 325.791.375,00

$ 261.504.465,00

Net Sales

$ 826.611.565,00

$ 434.692.225,00

$ 360.039.763,00

Cost of Good Sold

$ 386.182.208,00

$ 160.087.330,00

$ 136.634.153,00

Gross Result

$ 440.429.357,00

$ 274.604.895,00

$ 223.405.610,00

Administrative Expenses

$ 48.223.971,00

$ 27.534.437,00

$ 24.809.851,00

Selling Expenses

$ 238.458.031,00

$ 131.087.967,00

$ 118.743.286,00

Financial Income

$ 0,00

$ 0,00

$ 0,00

Other Expenses

$ -111.337.597,00

$ -51.695.581,00

$ -36.732.408,00

Final Result

$ 42.409.758,00

$ 64.286.910,00

$ 43.120.065,00

 

 

Balance Sheet Analysis

 

Indexes

30/11/2010

30/11/2009

30/11/2008

Current Ratio

147,27 %

499,67 %

390,37 %

Quick Ratio

89,22 %

374,69 %

260,49 %

Short Term Indebtedness

132,98 %

20,59 %

26,34 %

Debt to Equity Ratio

140,13 %

24,67 %

30,69 %

Long Term Assets to Total Assets

18,45 %

17,47 %

21,31 %

Fixed Assets to Equity

0,00 %

0,00 %

0,00 %

Total Assets to Total Liabilities

171,36 %

505,27 %

425,88 %

Debt Ratio

58,36 %

19,79 %

23,48 %

Equity Ratio

41,64 %

80,21 %

76,52 %

Investments to Assets Ratio

32,15 %

20,64 %

26,18 %

Current Investment

81,55 %

82,53 %

78,69 %

Stocks Aging Days

282,33 días

191,15 días

239,01 días

Day Sales

0,00 días

0,00 días

0,00 días

Trade Debtors To Assets

0,00 %

0,00 %

0,00 %

Total Assets Turnover

88,97 %

107,02 %

105,35 %

Net Worth Aging

213,64 %

133,43 %

137,68 %

Fixed Assets Aging

Infinito %

Infinito %

Infinito %

Gross Profit

46,72 %

36,83 %

37,95 %

Financial Expenses on Sales Ratio

0,00 %

0,00 %

0,00 %

Commercial Exp. on Sales Ratio

28,85 %

30,16 %

32,98 %

Administrative Exp. on Sales Ratio

5,83 %

6,33 %

6,89 %

 


Assets 

 

REAL ESTATE:
------------
- Virrey Loreto No.2477, Buenos Aires City, Repúblic of Argentina.

- Carlos Berg 3669 (CP. C1437 BEM), Buenos Aires City, Repúblic of Argentina. Whit surface of 14.500 m2.

 

 

Commercial References Consulted 

 

SMURFIT KAPPA S.A.

Credits:  $ 1.500.000
Payments: 30/60/90/120 days
Concept:  good.

 

 

Evolution and Results 

 

The joint review is dedicated to the manufacture and marketing of human medicines and pharmaceuticals.

For normal development of such efforts has made ??an important art infrastructure, counting his time with the tech support from its parent.

The plant has an installed production capacity in three shifts to produce annually about 700 million tablets, 75 million capsules, 20 million bottles and envelopes and put about 65 million units of finished product.

65% of the units are manufactured for the local market, 25% of exports to the Mercosur countries and the remaining 10% to local services for third parties.

The plant has a production surfaceof 14500 m2 and has ample opportunities for expansion.

It is widely entrenched in the local market and its products are renowned, being considered stable outlook.

FOREIGN TRADE:
--------------
In the last twelve months, it has made specific imports by u$s. 5.363.826 according to the following detail:

PUERTO RICO              1.228.228
EEUU                           1.131.462
BRASIL                         678.875
OTHERS                       2.325.261



SUPPLIERS:
----------
CARTOCOR S.A.
SMURFIT KAPPA S.A.

* 650 employees

 

 

Branches 

 

 

- Plant of production:

Carlos Berg 3669 (CP. C1437 BEM), Ciudad de Buenos Aires, República Argentina.

- Others address:

Avda. Diaz Velez 5044, Ciudad de Buenos Aires.
Carlos Berg 3635, Ciudad de Buenos Aires
Tte. Gral. J.D.Peron 4151, Ciudad de Buenos Aires
Avda. Cordoba 1889, Ciudad de Buenos Aires
Dr. Juan F. Aranguren 2701, Ciudad de Buenos Aires
San Blas 5543, Ciudad de Buenos Aires
Dr. Juan Finochietto 849, Ciudad de Buenos Aires
Colon 1161, Tres Arroyos, Buenos Aires
Balcarce 558, Toay, La Pampa
B.Mitre 50, Santa Rosa, La Pampa
Sarmiento 311, Trenque Lauquen, Buenos Aires.
2 de Abril s/nº, Trujuy, Buenos Aires
Avda. Rivadavia 26, Tandil, Buenos Aires.
Maipu 584, Tandil, Buenos Aires.
Fugl 855, Tandil, Buenos Aires
Mariano Moreno 2433, Bella Vista, Buenos Aires.
Ernesto Grant 235, Moron, Buenos Aires
Cangallo826, Temperley, Buenos Aires
Sitio de Montevideo 53, Lanus, Buenos Aires.

 

 

Payment Record and Credit Risk 

 

 

CITIBANK N.A.             Centralhouse

CREDIT RISK OCTOBER 2013
------------------------

AMERICAN EXPRESS      $ 2.224.200

Situation 1: normal.

INSURANCE:
----------
MAPFRE CIA.DE SEGUROS GENERALES S.A.

 

 

Concept 

 

It is commercially related to companies of this one and other places, good part of which offer its credit support without making until the moment objections on the modes of payment that it sustains.

* FULFILLMENT: NOT OBJECTED.

 

 

Final Opinion 

 

The lack of negative antecedents makes viable the credit relation with the company, by current credits and additional guarantees.

* APT FOR CREDITS

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.62.24

UK Pound

1

Rs.101.81

Euro

1

Rs.84.88

 

INFORMATION DETAILS

 

Report Prepared by :

MNL

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.